Spectrum Stock Gaps Down On Today's Open (SPPI)
NEW YORK (TheStreet) -- Shares of Spectrum Pharmaceuticals (Nasdaq:SPPI) were gapping down Thursday morning with an open price 11.6% lower than Wednesday's closing price. The stock closed at $12.21 Wednesday and opened today's trading at $10.79. The average volume for Spectrum has been 1.6 million shares per day over the past 30 days. Spectrum has a market cap of $880.1 million and is part of the health care sector and drugs industry. Shares are down 16.5% year to date as of the close of trading on Wednesday. Spectrum Pharmaceuticals, Inc., a biotechnology company, engages in acquiring, developing, and commercializing prescription drug products primarily in the areas of hematology and oncology. The company has a P/E ratio of 15.1, below the average drugs industry P/E ratio of 19.7 and below the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Spectrum as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. You can view the full Spectrum Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting DOWN to 95370 or select from multiple alert options.
Latest Headlines about SPPI
-
Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma
07:00AM 05/17/13
-
The 5 Dumbest Things on Wall Street This Week: May 17
07:00AM 05/17/13
-
SEC Is Investigating Spectrum Pharma
07:19AM 05/13/13
-
5 Stocks Poised to Break Out
02:10PM 05/10/13
-
Most Profitable Second Quarter Biotech Stocks
06:00AM 04/02/13
-
5 Dumbest Things 'April Fools' Quiz
07:00AM 03/29/13
-
TheStreet Ratings Top 10 Rating Changes
01:09PM 03/25/13
Latest from TheStreet Wire
-
Cubist Reaches New 52-Week High (CBST)
10:15AM 05/20/13
-
Alkermes Stock Hits New 52-Week High (ALKS)
10:09AM 05/20/13
-
Denbury Stock Hits New 52-Week High (DNR)
10:08AM 05/20/13
-
Wesco International Reaches New 52-Week High (WCC)
10:03AM 05/20/13
-
PNC Financial Services Group Inc Stock Buy Recommendation Reiterated (PNC)
10:01AM 05/20/13
-
Regeneron Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (REGN)
10:01AM 05/20/13
-
McKesson Inc. Stock Buy Recommendation Reiterated (MCK)
10:01AM 05/20/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
